Next Article in Journal
Rumphellaoic Acid A, a Novel Sesquiterpenoid from the Formosan Gorgonian Coral Rumphella antipathies
Next Article in Special Issue
Marine Pseudovibrio sp. as a Novel Source of Antimicrobials
Previous Article in Journal
Marine Nucleosides: Structure, Bioactivity, Synthesis and Biosynthesis
Previous Article in Special Issue
Global and Phylogenetic Distribution of Quorum Sensing Signals, Acyl Homoserine Lactones, in the Family of Vibrionaceae
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2014, 12(12), 5839-5855; doi:10.3390/md12125839

Chromomycin A2 Induces Autophagy in Melanoma Cells

1
Marine Sciences Institute, Federal University of Ceara, Fortaleza, Ceara 60165-081, Brazil
2
Department of Physiology and Pharmacology, Federal University of Ceara, Fortaleza, Ceará 60430-270, Brazil
3
Marine Sciences Department, Federal University of São Paulo, Santos, São Paulo 11030-400, Brazil
4
Department of Organic and Inorganic Chemistry, Federal University of Ceara, Fortaleza, CE 60021-970, Brazil
5
Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Granada 18016, Spain
*
Author to whom correspondence should be addressed.
Received: 22 August 2014 / Revised: 17 November 2014 / Accepted: 20 November 2014 / Published: 4 December 2014
(This article belongs to the Special Issue Bioactive Compounds from Marine Microbes)
View Full-Text   |   Download PDF [1041 KB, uploaded 24 February 2015]   |  

Abstract

The present study highlights the biological effects of chromomycin A2 toward metastatic melanoma cells in culture. Besides chromomycin A2, chromomycin A3 and demethylchromomycin A2 were also identified from the extract derived from Streptomyces sp., recovered from Paracuru Beach, located in the northeast region of Brazil. The cytotoxic activity of chromomycin A2 was evaluated across a panel of human tumor cell lines, which found IC50 values in the nM-range for exposures of 48 and 72 h. MALME-3M, a metastatic melanoma cell line, showed the highest sensitivity to chromomycin A2 after 48h incubation, and was chosen as a model to investigate this potent cytotoxic effect. Treatment with chromomycin A2 at 30 nM reduced cell proliferation, but had no significant effect upon cell viability. Additionally, chromomycin A2 induced accumulation of cells in G0/G1 phase of the cell cycle, with consequent reduction of S and G2/M and unbalanced expression of cyclins. Chromomycin A2 treated cells depicted several cellular fragments resembling autophagosomes and increased expression of proteins LC3-A and LC3-B. Moreover, exposure to chromomycin A2 also induced the appearance of acidic vacuolar organelles in treated cells. These features combined are suggestive of the induction of autophagy promoted by chromomycin A2, a feature not previously described for chromomycins. View Full-Text
Keywords: Streptomyces; autophagy; cytotoxicity; chromomycin; marine microorganisms; Brazil Streptomyces; autophagy; cytotoxicity; chromomycin; marine microorganisms; Brazil
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Guimarães, L.A.; Jimenez, P.C.; Sousa, T.S.; Freitas, H.P.S.; Rocha, D.D.; Wilke, D.V.; Martín, J.; Reyes, F.; Deusdênia Loiola Pessoa, O.; Costa-Lotufo, L.V. Chromomycin A2 Induces Autophagy in Melanoma Cells. Mar. Drugs 2014, 12, 5839-5855.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top